According to Bloomberg, fertility services provider Kindbody is attempting to raise USD 30 million to USD 50 million in a new funding round. The round is expected to value the company at USD 600 million pre-money, a significant decrease from its previous USD 1.8 billion valuation.
The company aims to complete the funding by mid-September. A new "blue-chip growth equity investor" plans to invest at least USD 10 million and has set the terms for this funding round.
Kindbody has recently faced challenges, including larger-than-projected operating losses and lower-than-expected usage of its services by client companies' employees. The company has been cutting costs by closing multiple clinics and has experienced turnover among its doctors.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.